First Quadrant’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-578
Closed -$42K 788
2020
Q1
$42K Sell
578
-1,588
-73% -$138K 0.01% 545
2019
Q4
$182K Sell
2,166
-2,285
-51% -$177K 0.02% 417
2019
Q3
$374K Sell
4,451
-578
-11% -$43.7K 0.04% 348
2019
Q2
$329K Sell
5,029
-8,701
-63% -$501K 0.02% 456
2019
Q1
$810K Buy
13,730
+4,437
+48% +$265K 0.06% 291
2018
Q4
$492K Sell
9,293
-416
-4% -$22.8K 0.04% 360
2018
Q3
$582K Sell
9,709
-4,144
-30% -$227K 0.01% 467
2018
Q2
$596K Buy
+13,853
New +$560K 0.01% 467
2017
Q4
Sell
-3,732
Closed -$119K 953
2017
Q3
$119K Buy
+3,732
New +$114K ﹤0.01% 778

Other funds holding MEDP

First Quadrant's MEDP Position: Q2 2020 in Review

First Quadrant sold out of Medpace (MEDP) in Q2 2020, closing a stake of 578 shares — an estimated $42K sold.

First Quadrant first reported a position in MEDP in Q3 2017 and held it in 9 quarters. The position peaked at $810K in Q1 2019. 277 funds tracked by Wall St. Rank hold MEDP as of Q2 2020.

  • First Quadrant reported no remaining Medpace position as of Q2 2020 after selling out during the quarter.
  • First Quadrant sold 578 Medpace shares in Q2 2020, an estimated $42K.
  • First Quadrant first reported a position in Medpace in Q3 2017 and held it in 9 quarters.
  • First Quadrant's Medpace position peaked at $810K in Q1 2019.
  • 277 funds tracked by Wall St. Rank held Medpace as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.